InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: shreya post# 1466

Saturday, 03/23/2013 4:12:06 PM

Saturday, March 23, 2013 4:12:06 PM

Post# of 40502
hepatitis C is still expected 1st quarter 2013. Many people are iffy on this because we only have one week left so don't know if there will be a small delay. Also HIV pennvax B therapeutic completed phase 1 and article has been sent to a publishing medical journal to publish the phase 1 results.

in 1st half 2013 expected:

influenza data

pandemic flu data

2013 expected :

Begin phase 1 HIV for pennvax GP

Begin phase 1 prostate cancer

More phase 2 Leukimia data, this time they will show BCR-ABL and other stuff

2nd half 2013:

Begin phase 1 for hepatitis C but not Chrontech's. This time it's INO's hep C drug INO-8000 and it doesn't use Standard of care like chronvac C. It will just be the vaccine with electropration alone targeting both genotype 1a and 1b hep c.

1st half 2014:

Begin phase 1 testing of Malaria vaccine

Phase 2 data for Cervical cancer out

Possiblities:

This is iffy but possible partnership on a pre clinical product is possible. CEO mentioned that INO is in pre clinical work on lung cancer vaccine and breast cancer vaccine. So that remains to be seen! GL to all
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News